Annual Cash & Cash Equivalents
$189.52 M
+$101.87 M+116.23%
December 31, 2023
Summary
- As of February 7, 2025, CLBT annual cash & cash equivalents is $189.52 million, with the most recent change of +$101.87 million (+116.23%) on December 31, 2023.
- During the last 3 years, CLBT annual cash & cash equivalents has risen by +$60.81 million (+47.24%).
- CLBT annual cash & cash equivalents is now at all-time high.
Performance
CLBT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$136.35 M
+$29.39 M+27.48%
September 30, 2024
Summary
- As of February 7, 2025, CLBT quarterly cash and cash equivalents is $136.35 million, with the most recent change of +$29.39 million (+27.48%) on September 30, 2024.
- Over the past year, CLBT quarterly cash and cash equivalents has dropped by -$717.00 thousand (-0.52%).
- CLBT quarterly cash and cash equivalents is now -28.05% below its all-time high of $189.52 million, reached on December 31, 2023.
Performance
CLBT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CLBT Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +116.2% | -0.5% |
3 y3 years | +47.2% | -0.5% |
5 y5 years | +147.6% | -0.5% |
CLBT Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +116.2% | -28.1% | +61.2% |
5 y | 5-year | at high | +147.6% | -28.1% | +61.2% |
alltime | all time | at high | +147.6% | -28.1% | +61.2% |
Cellebrite DI Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $136.35 M(+27.5%) |
Jun 2024 | - | $106.96 M(-12.6%) |
Mar 2024 | - | $122.43 M(-35.4%) |
Dec 2023 | $189.52 M(+116.2%) | $189.52 M(+38.3%) |
Sep 2023 | - | $137.07 M(+24.0%) |
Jun 2023 | - | $110.50 M(+11.6%) |
Mar 2023 | - | $98.97 M(+12.9%) |
Dec 2022 | $87.64 M | $87.64 M(+3.6%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2022 | - | $84.57 M(-7.8%) |
Jun 2022 | - | $91.69 M(-27.1%) |
Mar 2022 | - | $125.72 M(-13.9%) |
Dec 2021 | $145.97 M(+13.4%) | $145.97 M(+32.8%) |
Sep 2021 | - | $109.89 M(-33.9%) |
Jun 2021 | - | $166.29 M(+29.2%) |
Dec 2020 | $128.71 M(+68.1%) | $128.71 M |
Dec 2019 | $76.55 M | - |
FAQ
- What is Cellebrite DI annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Cellebrite DI?
- What is Cellebrite DI annual cash & cash equivalents year-on-year change?
- What is Cellebrite DI quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Cellebrite DI?
- What is Cellebrite DI quarterly cash and cash equivalents year-on-year change?
What is Cellebrite DI annual cash & cash equivalents?
The current annual cash & cash equivalents of CLBT is $189.52 M
What is the all time high annual cash & cash equivalents for Cellebrite DI?
Cellebrite DI all-time high annual cash & cash equivalents is $189.52 M
What is Cellebrite DI annual cash & cash equivalents year-on-year change?
Over the past year, CLBT annual cash & cash equivalents has changed by +$101.87 M (+116.23%)
What is Cellebrite DI quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CLBT is $136.35 M
What is the all time high quarterly cash and cash equivalents for Cellebrite DI?
Cellebrite DI all-time high quarterly cash and cash equivalents is $189.52 M
What is Cellebrite DI quarterly cash and cash equivalents year-on-year change?
Over the past year, CLBT quarterly cash and cash equivalents has changed by -$717.00 K (-0.52%)